GlassScriptPhysician profile
Heather Dalwadi
NPI 1922275890
$3,445.76
in general payments reported to CMS, 2019-2025
39 companies · $874 in 2025
The $874 reported for 2025 was more than what 78% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $288 · 2022: $737 · 2023: $937 · 2024: $610 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,336 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,336.38 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $373.97 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $373.90 | 2022-2025 | Zepbound, Jardiance, Emgality |
| Abbvie INC. | $346.40 | 2021-2025 | |
| Corcept Therapeutics | $286.26 | 2024-2025 | Korlym |
| Radius Health, INC. | $173.84 | 2022-2025 | Tymlos |
| Astellas Pharma US INC | $169.19 | 2023-2024 | Veozah |
| Beta Bionics, INC. | $140.65 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Amneal Pharmaceuticals LLC | $118.97 | 2021-2025 | Unithroid |
| Bayer Healthcare Pharmaceuticals INC. | $115.92 | 2021-2025 | |
| Dexcom, INC. | $110.99 | 2022-2023 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $101.40 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $97.63 | 2022-2024 | |
| Medtronic, INC. | $93.14 | 2022-2025 | Minimed 780g |
| Tandem Diabetes Care, INC. | $90.89 | 2021-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Nevro Corp. | $83.80 | 2022-2023 | Senza |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Dalwadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.